Published in J Appl Physiol Respir Environ Exerc Physiol on December 01, 1983
Tracheobronchial foreign bodies: presentation and management in children and adults. Chest (1999) 5.93
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Separation of components in fenestrated and branched endovascular grafting--branch protection or a potentially new mode of failure? Eur J Vasc Endovasc Surg (2008) 2.74
Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol (1990) 2.01
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol (1992) 1.94
Microsleep during a simplified maintenance of wakefulness test. A validation study of the OSLER test. Am J Respir Crit Care Med (2001) 1.57
Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J (1997) 1.49
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48
Management of simple snoring in adults. Monaldi Arch Chest Dis (1993) 1.42
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin. Thorax (1992) 1.40
Iatrogenic tracheobronchial lacerations. Ann Thorac Surg (1997) 1.38
[Spontaneous pneumothorax. Results of pleural talc therapy using thoracoscopy]. Rev Mal Respir (1995) 1.37
Reassessment of lung volume measurement by helium dilution and by body plethysmography in chronic air-flow obstruction. Am Rev Respir Dis (1982) 1.37
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34
Failure of body plethysmography in bronchial asthma. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.26
High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnoea. Eur Respir J (2003) 1.19
Magnetic relaxation in blood and blood clots. Magn Reson Med (1990) 1.17
Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. Chest (1995) 1.16
Demonstration of failure of body plethysmography in airway obstruction. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.15
Respiratory failure due to tracheobronchomalacia. Thorax (1996) 1.14
Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev (1997) 1.09
Ambulatory evaluation of sleep disturbance and therapeutic effects in sleep apnea syndrome by wrist activity monitoring. Am Rev Respir Dis (1987) 1.09
Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.07
Emotional laryngeal wheezing: a new syndrome. Am Rev Respir Dis (1983) 1.06
Alkhumra haemorrhagic fever: case report and infection control details. Br J Biomed Sci (2005) 1.06
Glottis opening and airway resistance. J Appl Physiol (1972) 1.06
Soft palate and oronasal breathing in humans. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.04
Smoking, lung function, and body weight. Br Med J (Clin Res Ed) (1983) 1.04
Normal pregnancy in primary alveolar hypoventilation treated with nocturnal nasal intermittent positive pressure ventilation. Eur Respir J (1995) 1.03
Failure of tonsil and nose surgery in adults with long-standing severe sleep apnea syndrome. Arch Intern Med (1989) 0.99
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol (1987) 0.98
Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial. Eur Respir J (2002) 0.96
Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest (1982) 0.95
Significance of small airway tests in middle-aged smokers. Am Rev Respir Dis (1981) 0.95
Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage. Am Rev Respir Dis (1985) 0.94
Smoking and pulmonary diffusing capacity. Scand J Respir Dis (1975) 0.94
Changes in lung function after smoking cessation: an assessment from a cross-sectional survey. Am Rev Respir Dis (1982) 0.93
The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go? Eur J Clin Microbiol Infect Dis (2012) 0.93
Lung diffusing capacity. Normal values in male smokers and non-smokers using the breath-holding technique. Scand J Respir Dis (1970) 0.92
Effects of nasal positive-pressure hyperventilation on the glottis in normal sleeping subjects. J Appl Physiol (1985) (1995) 0.92
Spontaneous favorable outcome of tracheal laceration. Chest (1991) 0.92
Frequency dependence of plethysmographic volume in healthy and asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.91
Weight loss as a treatment for obstructive sleep apnoea. Sleep Med Rev (2000) 0.90
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C. Haemophilia (2004) 0.90
Pattern of snoring in obstructive sleep apnea patients and in heavy snorers. Sleep (1991) 0.90
"Sensitive tests" are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Rev Respir Dis (1987) 0.89
Bronchial asthma following exposure to ECG ink. Ann Allergy (1982) 0.89
Upper airway anesthesia induces airflow limitation in awake humans. Am Rev Respir Dis (1992) 0.89
Pattern of breathing and ventilatory response to CO2 in subjects practicing hatha-yoga. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.89
The soft palate and breathing. Am Rev Respir Dis (1986) 0.88
The ion sensitive field effect transistor (ISFET) pH electrode: a new sensor for long term ambulatory pH monitoring. Gut (1991) 0.86
Infants are not obligatory nasal breathers. Am Rev Respir Dis (1985) 0.86
Reevaluation of the radiographic method for measurement of total lung capacity. Bull Eur Physiopathol Respir (1986) 0.86
De novo interstitial duplication 4(q28.1q35) associated with choanal atresia. J Paediatr Child Health (2004) 0.86
Pattern of inhalation of tobacco smoke in pipe, cigarette, and never smokers. Am Rev Respir Dis (1985) 0.86
Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J Hosp Infect (2005) 0.86
Low-level fructan supplementation of dogs enhances nutrient digestion and modifies stool metabolite concentrations, but does not alter fecal microbiota populations. J Anim Sci (2009) 0.85
Effects of nasal positive-pressure hyperventilation on the glottis in normal awake subjects. J Appl Physiol (1985) (1995) 0.84
Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur Respir J (2006) 0.84
Ventilatory and diaphragmatic EMG responses to negative-pressure ventilation in airflow obstruction. J Appl Physiol (1985) (1988) 0.84
Bronchial asthma without increased airway reactivity. Eur J Respir Dis (1982) 0.84
Effect of alveolar volume on the interpretation of single breath DLCO. Respir Med (1997) 0.83
A whole water catchment approach to investigating the origin and distribution of Cryptosporidium species. J Appl Microbiol (2011) 0.83
Cyclorraphan yolk proteins and lepidopteran minor yolk proteins originate from two unrelated lipase families. Insect Mol Biol (2004) 0.83
Nasal occlusion during sleep in normal and near-miss for sudden death syndrome infants. Bull Eur Physiopathol Respir (1987) 0.83
Influence of the respiratory route on the resting breathing pattern in humans. Am Rev Respir Dis (1985) 0.83
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group. Med Oncol Tumor Pharmacother (1989) 0.83
Pulmonary function in workers with chronic exposure to cadmium oxide fumes. Int Arch Arbeitsmed (1970) 0.83
Pulmonary function in status asthmaticus: effect of therapy. Thorax (1970) 0.82
Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol (2007) 0.82
Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med (2006) 0.81
Adolescents with special health care needs in transition: three life histories. Soc Work Health Care (2000) 0.81
Determinants of Fi,O2 with oxygen supplementation during noninvasive two-level positive pressure ventilation. Eur Respir J (2002) 0.81
Maximum respiratory pressures in trumpet players. Chest (1993) 0.81
Cure of sleep apnea syndrome after long-term nasal continuous positive airway pressure therapy and weight loss. Sleep (1989) 0.81
An anatomic classification of the ethmoidal bulla. Otolaryngol Head Neck Surg (2001) 0.81
Absence of nasal air flow during pursed lips breathing. The soft palate mechanisms. Am Rev Respir Dis (1983) 0.80
Movement arousals and sleep-related disordered breathing in adults. Am J Respir Crit Care Med (1996) 0.80
Upper airway obstruction during nasal intermittent positive-pressure hyperventilation in sleep. Lancet (1991) 0.80
Decay of intestinal enterococci concentrations in high-energy estuarine and coastal waters: towards real-time T90 values for modelling faecal indicators in recreational waters. Water Res (2004) 0.80
Effects of Breathe Right on snoring: a polysomnographic study. Respir Med (1998) 0.80
Inflection point on transpulmonary pressure-volume curves and closing volume. J Appl Physiol (1975) 0.80
Sleep fragmentation: comparison of two definitions of short arousals during sleep in OSAS patients. Eur Respir J (2001) 0.79